Elevance Health (ELV) Cash from Investing Activities (2010 - 2026)

Elevance Health (ELV) has 17 years of Cash from Investing Activities data on file, last reported at -$1.6 billion in Q1 2026.

• Quarterly Cash from Investing Activities fell 1694.17% year-over-year to -$1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 billion (down 12.16% YoY) and the FY2025 annual result came in at -$1.3 billion, up 73.99% from the prior year.
• Cash from Investing Activities slipped to -$1.6 billion in Q1 2026 per ELV's latest filing, from $464.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $464.0 million in Q4 2025 and bottomed at -$3.2 billion in Q1 2023.
• The 5-year median for Cash from Investing Activities is -$1.0 billion (2023), against an average of -$1.1 billion.
• The widest annual swing landed in 2022, when Cash from Investing Activities jumped 129.92%; it then tumbled 1694.17% in 2026.
• Tracing ELV's Cash from Investing Activities over 5 years: stood at $289.0 million in 2022, then slumped by 456.06% to -$1.0 billion in 2023, then slumped by 59.18% to -$1.6 billion in 2024, then surged by 128.33% to $464.0 million in 2025, then slumped by 453.88% to -$1.6 billion in 2026.
• Per Business Quant, the three latest ELV Cash from Investing Activities figures stand at -$1.6 billion (Q1 2026), $464.0 million (Q4 2025), and -$1.2 billion (Q3 2025).

Peer Comparison